Atorvastatin Versus Placebo for Prostate Cancer Before Radical Prostatectomy—A Randomized, Double-blind, Placebo-controlled Clinical Trial-Reference-Cited by-同舟云学术

Atorvastatin Versus Placebo for Prostate Cancer Before Radical Prostatectomy—A Randomized, Double-blind, Placebo-controlled Clinical Trial

Published:2018-12 Issue:6 Volume:74 Page:697-701
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Murtola Teemu J.,Syvälä Heimo,Tolonen Teemu,Helminen Mika,Riikonen Jarno,Koskimäki Juha,Pakarainen Tomi,Kaipia Antti,Isotalo Taina,Kujala Paula,Tammela Teuvo L.J.

Publisher

Elsevier BV

Subject

Urology

Reference10 articles.

1. The current evidence on statin use and prostate cancer prevention: are we there yet?;Alfaqih;Nat Rev Urol,2017

2. Statin use at the time of initiation of androgen deprivation therapy and time to progression in patients with hormone-sensitive prostate cancer;Harshman;JAMA Oncol,2015

3. Preoperative statin use associated with lower PSA but similar prostate size and histopathologic outcomes: implications for active surveillance?;Stensland;Urol J,2017

4. Comparative effects of high and low-dose simvastatin on prostate epithelial cells: the role of LDL;Murtola;Eur J Pharmacol,2011

5. Consensus development of a histopathological classification system for chronic prostatic inflammation;Nickel;BJU Int,2001

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statin Concentration in Prostatic Tissue is Subtype- and Dose-dependent;Urology;2024-08

2. Oleic acid-PPARγ-FABP4 loop fuels cholangiocarcinoma colonization in lymph node metastases microenvironment;Hepatology;2024-02-20

3. Emerging Trends of Nanomedicines in the Management of Prostate Cancer: Perspectives and Potential Applications;Pharmaceutics;2024-02-20

4. Prostate Cancer and the Mevalonate Pathway;International Journal of Molecular Sciences;2024-02-10

5. The Impact of Atorvastatin on Intraprostatic Biomarkers – Prognostic Value of 3ls-Score – Follow-Up of Esto1-Trial;2024